GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (LTS:0RIM) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Gensight Biologics (LTS:0RIM) Future 3-5Y EPS without NRI Growth Rate : -108.53 (As of May. 20, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Gensight Biologics Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Gensight Biologics's Future 3-5Y EPS without NRI Growth Rate is -108.53.

Competitive Comparison of Gensight Biologics's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Gensight Biologics's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gensight Biologics's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gensight Biologics's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Gensight Biologics's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Gensight Biologics  (LTS:0RIM) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Gensight Biologics Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Gensight Biologics's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Gensight Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (LTS:0RIM) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XPAR:ALGAE XPAR:ABNX XPAR:ALGEN XPAR:POXEL XPAR:ALDVI XPAR:AELIS XPAR:ALCOX XPAR:ALVAL XPAR:ALNFL XPAR:ALPAT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
SIGHT:France
Address
74, rue du Faubourg Saint-Antoine, Paris, FRA, 75012
Website
https://www.gensight-biologics.com
Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence and Optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group's focus is on ophthalmology, where it develops product candidates to restore eyesight to patients suffering from retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.

Gensight Biologics Headlines

No Headlines